CN1314153A - 矿物盐组合物及其用途 - Google Patents
矿物盐组合物及其用途 Download PDFInfo
- Publication number
- CN1314153A CN1314153A CN 01109707 CN01109707A CN1314153A CN 1314153 A CN1314153 A CN 1314153A CN 01109707 CN01109707 CN 01109707 CN 01109707 A CN01109707 A CN 01109707A CN 1314153 A CN1314153 A CN 1314153A
- Authority
- CN
- China
- Prior art keywords
- mineral salt
- ion
- mineral
- salt composition
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 72
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 66
- 239000011707 mineral Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 97
- 235000010755 mineral Nutrition 0.000 claims abstract description 65
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 31
- 239000000843 powder Substances 0.000 claims abstract description 31
- 239000011780 sodium chloride Substances 0.000 claims abstract description 25
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 14
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960000282 metronidazole Drugs 0.000 claims abstract description 12
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004327 boric acid Substances 0.000 claims abstract description 11
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 10
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 claims abstract description 6
- 235000011152 sodium sulphate Nutrition 0.000 claims abstract description 6
- 206010048768 Dermatosis Diseases 0.000 claims abstract description 5
- 229910001416 lithium ion Inorganic materials 0.000 claims abstract description 5
- VGTPKLINSHNZRD-UHFFFAOYSA-N oxoborinic acid Chemical compound OB=O VGTPKLINSHNZRD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 208000017520 skin disease Diseases 0.000 claims abstract description 5
- 229910001427 strontium ion Inorganic materials 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 229910052705 radium Inorganic materials 0.000 claims description 6
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 4
- 239000005639 Lauric acid Substances 0.000 claims description 4
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 4
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 claims description 4
- 125000000223 arsonoyl group Chemical group [H][As](*)(*)=O 0.000 claims description 4
- 229910001422 barium ion Inorganic materials 0.000 claims description 4
- 230000003796 beauty Effects 0.000 claims description 4
- 229940006460 bromide ion Drugs 0.000 claims description 4
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 claims description 4
- 229910000020 calcium bicarbonate Inorganic materials 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 claims description 4
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 4
- 229940006461 iodide ion Drugs 0.000 claims description 4
- -1 iron ion Chemical class 0.000 claims description 4
- 229910001437 manganese ion Inorganic materials 0.000 claims description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 4
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 claims description 4
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 claims description 3
- 229910052776 Thorium Inorganic materials 0.000 claims description 3
- 229910052770 Uranium Inorganic materials 0.000 claims description 3
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 2
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 2
- 240000005385 Jasminum sambac Species 0.000 claims description 2
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 241000233855 Orchidaceae Species 0.000 claims description 2
- 244000141698 Prunus lannesiana Species 0.000 claims description 2
- 235000014001 Prunus serrulata Nutrition 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 235000009392 Vitis Nutrition 0.000 claims description 2
- 241000219095 Vitis Species 0.000 claims description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 2
- HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 235000018219 lavender Nutrition 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 230000004060 metabolic process Effects 0.000 abstract description 9
- 150000002500 ions Chemical class 0.000 abstract description 6
- 239000011573 trace mineral Substances 0.000 abstract description 4
- 235000013619 trace mineral Nutrition 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000002131 composite material Substances 0.000 abstract description 2
- 235000011132 calcium sulphate Nutrition 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- 229940097572 chloromycetin Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000036541 health Effects 0.000 description 13
- 239000000686 essence Substances 0.000 description 9
- 210000003722 extracellular fluid Anatomy 0.000 description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000002977 intracellular fluid Anatomy 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052704 radon Inorganic materials 0.000 description 3
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229910052712 strontium Inorganic materials 0.000 description 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000018958 Gardenia augusta Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 101100165177 Caenorhabditis elegans bath-15 gene Proteins 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- VHCQVGQULWFQTM-VOTSOKGWSA-N Rubone Chemical compound COC1=CC(OC)=CC(O)=C1C(=O)\C=C\C1=CC(OC)=C(OC)C=C1OC VHCQVGQULWFQTM-VOTSOKGWSA-N 0.000 description 1
- VHCQVGQULWFQTM-UHFFFAOYSA-N Rubone Natural products COC1=CC(OC)=CC(O)=C1C(=O)C=CC1=CC(OC)=C(OC)C=C1OC VHCQVGQULWFQTM-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000005442 atmospheric precipitation Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910001578 chloride mineral Inorganic materials 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000005413 snowmelt Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明属于矿物盐领域,特别涉及一种以氯化钠为主要成份的矿物盐组合物及其用途。该矿物盐组合物包括氯化钠、硫酸钠、硫酸镁、硫酸钙、偏硼酸、锶离子、锰离子、溴离子、锂离子、铁离子、氟离子和镭(Ra226)7.89×10-13－4.10×10-12g/L等一些人体所需的矿物微量元素;以基于矿物盐的重量百分比计,向其干燥后所形成的矿物盐中加入甲硝唑粉、氯霉素粉、硼酸粉或它们的混合物等物质。该矿物盐组合物用于美容、健身减肥及治疗皮肤病。并能改善人体新陈代谢,提高免疫力;且无毒无副作用。
Description
本发明属于矿物盐领域，特别涉及一种以氯化钠为主要成份的矿物盐组合物及其用途。
最原始的生物诞生于远古的海水中，人体重量的三分之二是水份，人的体液由细胞内液和细胞外液构成，盐所含的“钠”以阳离子形式在细胞外液中维持人体晶体渗透压，钠离子与钾离子共同维持细胞内外渗透压的平衡。使人体内外新陈代谢正常进行，盐是人类不可缺少的成份，也是生命的源泉。
与化学合成盐不同是矿物盐取源于天然矿泉，有苦涩味，结晶颗粒形态不规律、易受潮。最重要的是矿物盐含有多种对人体皮肤有特殊保健作用的钾、镁、铁、钙、碘、锶、硫磺等矿物元素，能促进人体血液循环，调节人体新陈代谢，平衡油脂，收缩毛孔，有效地延缓衰老，具有自然杀菌，抑制暗疮产生的功效。这是其它化学盐不能比拟的。
随着现代文明的发展，人们对美容保健有更高层次的要求，越来越多的人期望得到天然、无毒、安全的美容保健产品。矿盐美容保健的风气，目前已在欧洲、日本、美国等地形成，但在这些众多的美容保健品中，由于其主要组份矿盐的成份不同，所以导致了这些美容保健品的功效也不相同，而且其价格的昂贵，也给消费者造成了经济负担，找到一种即经济又能起到美容保健作用的理想保健品，是人们梦寐以求的。
本发明的目的在于提供一种价格低廉的矿物盐组合物，该组合物产品可用于美容保健。通过向天然矿物盐中加入一些具有杀菌和保健功效的天然成份，使其生产出来的美容保健品不但能够对人体的皮肤起到保健作用，而且还具有杀菌消毒功能；用其盐水擦身，在洗浴护肤的同时还能达到治愈皮肤病的目的。
本发明的矿物盐水是取自新疆托克逊县吐孜鲁克湖水，其特征在于所说的矿物盐组合物是向由新疆托克逊县吐孜鲁克湖水制成的矿物盐中加入甲硝唑粉、氯霉素粉、硼酸粉或它们的混合物，该矿物盐水中含有氯化钠150-263g/L、硫酸钠31-130g/L、硫酸镁8-16g/L、硫酸钙0.5-1.5g/L、偏硼酸(HBO2)49-335mg/L、锶离子10-26mg/L、锰离子1.3-4.8mg/L、溴离子12-18mg/L、锂离子2-3mg/L、铁离子0.2-5mg/L、氟离子1.5-4mg/L和镭(Ra226)7.89×10-13-4.10×10-12g/L。
所述的矿物盐水进一步含有钡离子0.04-0.1mg/L、碘离子0.4-0.7mg/L、HAsO3(砷水)小于0.01mg/L、碳酸钙0.1-0.5g/L、碳酸氢钙0.1-0.3g/L、偏硅酸(H2SiO3)5.5-11.50mg/L、HPO3小于0.01mg/L、铀563-564μg/L、钍2-2.4μg/L，以及锌离子小于0.235mg/L等一些人体所需的矿物微量元素。
将该矿物盐水进行日晒或采用其它手段，使其中的水份蒸发，得到干燥的矿物盐。以基于矿物盐的重量百分比计，向其干燥后所形成的矿物盐中加入甲硝唑粉3.0-3.2％、氯霉素粉3.0-3.2％、硼酸粉4.0-4.5％或它们的混合物。
以基于矿物盐的重量百分比计，可进一步向本发明的矿物盐组合物中加入表面活性剂3.0-3.5％、脂肪酸2.0-2.5％、食用香精0.08-0.1％或它们的混合物。
所述的表面活性剂可以是甘油单硬脂酸酯或失水山梨醇硬脂酸酯等；所述的脂肪酸可以是月桂酸、硬脂酸或柠檬酸等；所述的食用香精是带有玫瑰、白兰、茉莉、熏衣草、樱花、薄荷、柚子、兰草、桅子、衣兰草、苹果、草莓、木瓜、柠檬、桃子或葡萄等味的香精。
作为本发明矿物盐主要成份的矿物盐水，是选用我国新疆托克逊县吐孜鲁克湖水，该处的矿泉水地处我国最低的吐鲁番盆地，是由天山融雪和大气降水经过裂隙渗入到地下深处而涌出地表形成的矿泉水。在其循环运动中，长期与岩石相接触，使岩石风化水解，一些组份变成易溶于水的组份，使水的矿化度增加，而构成盐湖卤水。该水无异臭、异色、无异物、味咸，矿化度达到288-304g/L，是氯化物、硫酸盐复合盐类泉。
同时水中还含有一定量的游离二氧化碳气体和可溶硅酸与锂、锌、碘、氟等活性离于成份，是有着特殊效果的盐类矿泉水，经临床验证，对皮肤病有明显疗效，并能促进新陈代谢，调节五腑六脏，可作为浴疗开发利用。
镭泉又叫氡泉。放射性元素(Ra)蜕变产生的放射性气体氡溶于水中，氡浴有增强和调节机体的免疫功能和消炎止痛作用；锶是人体所必需的微量元素，与骨骼形成密切相关，与神经和肌肉的兴奋有关，氯化物矿泉能降低神经系统的兴奋性，对治疗神经痛有较好的效果，也能促进炎性渗出物的吸收和组织再生。硫酸镁、硫酸钠都是常用泻下药物，有降低血压，调整胃肠机能而致腹泻，对于便秘、肥胖有治疗作用，还能促进胆汁分泌和排出，防止胆石生成，对于肝胆疾病有效。
本发明首选薄荷醇作为食用香精加入矿物盐中，因为薄荷醇是一种无色针状结晶体，具有清凉香味，是用薄荷油冷却结晶法得到的。具有消毒、消炎、退红及醒脑和调节大脑等作用。
本发明所述的氯霉素粉是一种常规广谱抗生素，对革兰氏阳性、阴性细菌、立克次体、衣原体、支原体有较强杀菌作用。
甲硝唑粉又谓灭滴灵，能抑制杀灭革兰氏阴性、阳性细菌，可杀灭滴虫、原虫，水溶性好。
硼酸粉是一种无色透明、结晶或粉末状，对皮肤有润滑作用，溶于水时有一定杀菌作用。
本发明所采用的添加剂均可由市场购得。
在将本发明的矿物盐组合物作为发泡浴盐使用时，其所加入的表面活性剂能使污垢膨胀溶解，提高去除污垢效果。脂肪酸能与碱起化学变化、起泡好、易冲洗干净并不使皮肤油性过分丧失，故不使皮肤产生紧绷感。
作为本发明矿物盐主要成份的矿物盐水，是取源于我国新疆托克逊县吐孜鲁克天然盐类医疗矿泉，其含有稀有的锶、镭、钠、钙、镁、碘、铁等十多种人体所需元素及稀有微量元素，恰当的离子浓度能渗透皮肤生物膜，平衡油脂，消除红肿，减少渗出，促使病灶吸收，能直接杀菌抗病毒；并能改善人体新陈代谢，提高免疫力；且无毒无副作用。具有治疗范围广，使用简便、安全、无毒的特点，特别对一些病程长、易复发的皮肤病有很好的疗效。
包括人类在内，在路上生活的动物，都在体内有着和海水差不多相似的成份。人体的体液，是由细胞内液和细胞外液构成。两者是隔着细胞膜在一起的，此间物质的出入(细胞内液是从细胞外液摄取营养，再把不必要的老废物送回细胞外液)是经过浸透压力的差异而进行的，两者若不平衡的话，就会在体内发生异常而变成疾病，对于这种调节作用(浸透压调整)，盐就发挥了重要作用。
盐所含的(钠)在细胞外液中作为阳离子维持人体的渗透压，防止过多的水份由血液中渗入邻近组织。“钾”为细胞内体液中主要的阳离子，负责细胞内水份的平衡，与钠离子共同的作用，维持细胞内外体液渗透压的平衡，活化细胞与维持肌肉及神经的活动性。
本发明的矿物盐组合物的主要作用，是对皮肤予以刺激，进而刺激皮肤的末梢神经，以至于达到大脑延脑及背髓，并渐渐地影响到呼吸器官及循环器官，而对于新陈代谢或所谓内分泌的中枢作反射的刺激。
受到刺激的皮肤和血管，发生收缩作用，但以后逐渐扩大而开始活泼起来，于是毛细现象发生效力，血液的流通加速，因而达到促进血液循环及代谢功能，皮肤光泽、紧实而有强性。
本发明矿物盐组合物的生产过程如下：
资源地采集→过滤→干燥→筛选→加入添加剂(添加食用香精、脂肪酸、表面活性剂、硼酸粉、甲硝唑粉、氯霉素粉)→混合→成品。
本发明的矿物盐组合物可以用于美容、健身减肥及治疗皮肤病，并能改善人体新陈代谢，提高免疫力；且无毒无副作用。
本发明的矿物盐组合物的使用可以采用盐浴或者抹盐。所用矿物盐组合物的剂量，可依病的症状的不同而增减矿物盐剂量，其与市场上现有的矿物盐使用方法基本一样。
本发明的矿物盐组合物在作为浴盐使用时，一般将矿物盐组合物加入温水中，配成3-5wt％浓度左右，直接用于浸泡15-20分钟。
人体进入自然盐浴后，盐粒附着于身体，整个肌肤形成由盐膜包裹的状态，汗腺也被盐阻塞，体温外散缓慢，故能使身体温暖。身体温热，血液循环顺畅，新陈代谢提高。体内的废物就能迅速运送到肾脏，进而排出体外。废物中包括乳酸这种造成酸痛的疲劳物质，这种物质若能迅速排出体外，就能缓和疼痛或酸痛。因为身体温热，也能使肌肉、关节变得柔软。矿物温泉水对于肌肉与关节疼痛、风湿、肩膀酸痛有效，就是由于这种作用之故。
如果采用抹盐方法，将盐抹在皮肤上，盐会溶化形成一层薄膜，使体温不致流失。再者，盐粒非常粗糙，利用这种颗粒摩擦身体，也具有清洁的效果，能去除阻塞毛细孔的污垢，使皮肤的呼吸畅顺。给予皮肤适度的刺激，可以软化硬脂肪，具有使其强健的效果，达到减肥的目的。
此外，用手掌擦身体，也能促进东洋医学中所谓的(气)顺畅，使心情放松，有助于缓解压力。
沐浴时使用本发明的矿物盐组合物可以达到如下功效(加入食用香精效果更好)。
一．消除疲劳，使人精神舒畅。
二．补充肌肤所流失的盐分及营养。
三．保护肌肤，避免皮肤干裂。
四．促进血液循环，永保肌肤健康具有活力。
五．促进新陈代谢，防止皮肤老化和松弛。
六．使肌肤润滑，柔软去除体臭。
七．对皮肤、肌肉、骨骼有关的慢性病有特别的效果。
八．加入的食用香精更能对人的心灵及情绪有相当大的安抚作
用。
下面结合实施例对本发明的技术方案作进一步的描述。
实施例1．
首先从资源地新疆托克逊县吐孜鲁克天然盐类医疗矿泉抽取盐水→过滤器过滤→日晒干燥→筛选→添加薄荷醇、甘油单硬脂酸酯、月桂酸→硼酸粉、甲硝唑粉→混合→成品。
所取盐水中含有氯化钠150g/L、硫酸钠40g/L、硫酸镁10g/L、硫酸钙0.5g/L、偏硼酸60mg/L、锶离子16mg/L、锰离子2mg/L、溴离子13mg/L、锂离子2.5mg/L、铁离子0.2mg/L、氟离子1.5mg/L、镭(Ra226)7.89×10-13g/L、钡离子0.04mg/L、碘离子0.4mg/L、HAsO30.01mg/L、碳酸钙0.1g/L、碳酸氢钙0.2g/L、偏硅酸5.5mg/L、HPO3小于0.01mg/L。
以基于矿物盐的重量百分比计，向上述经自然风晒干燥形成的矿物盐中加入薄荷醇0.09％，甘油单硬脂酸酯3.0％，月桂酸2.1％，硼酸粉4.0％，甲硝唑粉3.0％。
实施例2．
首先从资源地新疆托克逊县吐孜鲁克天然盐类医疗矿泉抽取盐水→过滤器过滤→干燥→筛选→添加食用茉莉香精→硼酸粉、甲硝唑粉、氯霉素粉→混合→成品。
所取盐水中含有氯化钠200g/L、硫酸钠100g/L、硫酸镁81g/L、硫酸钙1.5g/L、偏硼酸250mg/L、锶离子12mg/L、锰离子1.3mg/L、溴离子18mg/L、锂离子3mg/L、铁离子0.3mg/L、氟离子2mg/L、镭(Ra226)2.0×10-12g/L、钡离子0.09mg/L、碘离子0.6mg/L、HAsO3小于0.01mg/L、碳酸钙0.2g/L、碳酸氢钙0.2g/L、偏硅酸5.5mg/L、HPO3小于0.01mg/L、铀563μg/L、钍2.1μg/L、离子小于0.235mg/L。
以基于矿物盐的重量百分比计，向上述经自然风晒干燥形成的盐中加入食用茉莉香精0.08％，硼酸粉3.0％，甲硝唑粉3.0％，氯霉素粉3.0％。
实施例3．
潘××，男、48岁、干部。左足底跟部胼胝十余年，取实施例2的产品约30g加入100ml温水中浸泡15分钟，再用干矿盐在患处按摩5分钟，坚持每日一次，十天后病灶变小、软化、治愈。
王××，女、35岁。患脚气多年，取实施例2的产品，配成3％浓度溶液，坚持每天泡脚15分钟，7天后病灶收敛，止痒、退红，效果显著。
李××，女、40岁。肥胖，身高1,56m，体重70kg，腰围90cm，为减去腹部脂肪，取实施例2的产品，放铁锅炒热装入布袋，敷于腹部需减肥部位，用保鲜膜包裹30分钟，3天后，腹围减少5cm显效。
唐××，男、45岁。牛皮癣，两小腿2×2cm，对称分布，臀部2×2cm各一处，取实施例1的产品，配成5％溶液，每天浸泡一次，15天后患处脱屑，一个月全愈。
Claims (9)
1．一种矿物盐组合物，其特征在于所说的矿物盐组合物是向由新疆托克逊县吐孜鲁克湖水制成的矿物盐中加入甲硝唑粉、氯霉素粉、硼酸粉或它们的混合物，该矿物盐水中含有氯化钠150-263g/L、硫酸钠31-130g/L、硫酸镁8-16g/L、硫酸钙0.5-1.5g/L、偏硼酸(HBO2)49-335mg/L、锶离子10-26mg/L、锰离子1.3-4.8mg/L、溴离子12-18mg/L、锂离子2-3mg/L、铁离子0.2-5mg/L、氟离子1.5-4mg/L和镭(Ra226)7.89×10-13-4.10×10-12g/L；
将该矿物盐水进行日晒或其它手段，使其中的水份蒸发，得到干燥的矿物盐；以基于矿物盐的重量百分比计，向其干燥后所形成的矿物盐中加入甲硝唑粉3.0-3.2％、氯霉素粉3.0-3.2％、硼酸粉4.0-4.5％或它们的混合物。
2．如权利要求1所述的矿物盐组合物，其特征在于：所述的矿物盐水中进一步含有钡离子0.04-0.1mg/L、碘离子0.4-0.7mg/L、HAsO3小于0.01mg/L、碳酸钙0.1-0.5g/L、碳酸氢钙0.1-0.3g/L、偏硅酸5.5-11.50mg/L、HPO3小于0.01mg/L。
3．如权利要求1或2所述的矿物盐组合物，其特征在于：所述的矿物盐水中进一步含有铀563-564μg/L、钍2-2.4μg/L。
4．如权利要求3所述的矿物盐组合物，其特征在于：所述的矿物盐水中进一步含有锌离子小于0.235mg/L。
5．如权利要求1所述的矿物盐组合物，其特征在于：以基于矿物盐的重量百分比计，所述的矿物盐组合物中进一步加入表面活性剂3.0-3.5％、脂肪酸2.0-2.5％、食用香精0.08-0.1％或它们的混合物。
6．如权利要求5所述的矿物盐组合物，其特征在于：所述的表面活性剂是甘油单硬脂酸酯或失水山梨醇硬脂酸酯。
7．如权利要求5所述的矿物盐组合物，其特征在于：所述的脂肪酸是月桂酸、硬脂酸或柠檬酸。
8．如权利要求5所述的矿物盐组合物，其特征在于：所述的食用香精是带有玫瑰、白兰、茉莉、熏衣草、樱花、薄荷、柚子、兰草、桅子、衣兰草、苹果、草莓、木瓜、柠檬、桃子或葡萄味的香精。
9．如权利要求1-8所述的矿物盐组合物的用途，其特征在于：该矿物盐组合物用于美容、健身减肥及治疗皮肤病。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011097078A CN1153572C (zh) | 2001-03-19 | 2001-03-19 | 矿物盐组合物及其用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011097078A CN1153572C (zh) | 2001-03-19 | 2001-03-19 | 矿物盐组合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1314153A true CN1314153A (zh) | 2001-09-26 |
| CN1153572C CN1153572C (zh) | 2004-06-16 |
Family
ID=4658097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011097078A Expired - Fee Related CN1153572C (zh) | 2001-03-19 | 2001-03-19 | 矿物盐组合物及其用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1153572C (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100341529C (zh) * | 2005-01-21 | 2007-10-10 | 西藏宇妥藏药研究有限公司 | 一种具有药用及保健作用的含盐藏药组合物及其制备方法 |
| CN108158863A (zh) * | 2018-02-06 | 2018-06-15 | 赵朝民 | 肌肤活力水及其制备方法 |
-
2001
- 2001-03-19 CN CNB011097078A patent/CN1153572C/zh not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100341529C (zh) * | 2005-01-21 | 2007-10-10 | 西藏宇妥藏药研究有限公司 | 一种具有药用及保健作用的含盐藏药组合物及其制备方法 |
| CN108158863A (zh) * | 2018-02-06 | 2018-06-15 | 赵朝民 | 肌肤活力水及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1153572C (zh) | 2004-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20110085026A (ko) | 천연약제를 이용한 기능성 건강식품 제조방법 및 상기 제조방법에 의해 제조된 기능성 건강식품 | |
| CN107432847B (zh) | 清洁与清凉皮肤的组合物和化妆品 | |
| CN102038923A (zh) | 一种治疗头皮屑的药物 | |
| CN102631557B (zh) | 治疗白内障、外障、老花眼和近视中药组合物及制备方法 | |
| CN1900255A (zh) | 男性健美长寿液 | |
| CN1153572C (zh) | 矿物盐组合物及其用途 | |
| CN107137548A (zh) | 一种治疗各种骨病痛症的中药组合物 | |
| CN113069519B (zh) | 一种抗炎止痒洗发方及其制备方法和使用方法 | |
| CN101036620A (zh) | 一种利用各种盐类矿物资源进行游乐保健的方法 | |
| KR101685686B1 (ko) | 천일염을 이용한 스크럽 화장료 조성물 | |
| CN1416805A (zh) | 天然中药玉珠美容养颜面膜及制备方法 | |
| KR101969983B1 (ko) | 토판염을 함유한 탈모개선 샴푸 조성물 및 이의 제조방법 | |
| CN102671180B (zh) | 一种治疗风湿腰痛的药物及其制备方法 | |
| CN1481828A (zh) | 虫草枸杞中草药滋补保健药酒 | |
| CN109621205A (zh) | 一种排毒祛堵养生方法 | |
| CN103463597B (zh) | 一种治疗痛风的保健药物 | |
| KR19990007655A (ko) | 세리사이트를 사용한 구강용, 미용용, 농축산용, 찜질용 및 정수용 조성물과 건축용 마감재 | |
| US20050123651A1 (en) | Mineral water composition | |
| CN106729118A (zh) | 一种治疗肾盂肾炎的药物及其制备方法 | |
| CN1090933C (zh) | 祛斑养颜面霜 | |
| CN106256359A (zh) | 一种麻醉科用于治疗癌性疼痛的药物组合物 | |
| KR100463747B1 (ko) | 인공온천 입욕용 조성물 | |
| KR101891212B1 (ko) | 천일염 및 남실을 함유하는 아이 필로우 및 그 제조방법 | |
| RU2227035C1 (ru) | Состав для профилактики и лечения фиброзно-кистозной мастопатии | |
| CN1305720A (zh) | 利用天然矿泉水制备的消毒液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING CITYZHONGXUN ZETONG TECHNOLOGY CO.,LTD. Free format text: FORMER OWNER: ZHANG GUIHUA Effective date: 20081010 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20081010 Address after: Beijing city Fengtai District Lianhuachi Sirirath building 18 Warburg apartment room B409-410 Patentee after: In the city of Beijing on Tong Technology Co. Ltd. Address before: Guangdong Province, Shenzhen Shennan Road Jiahe building block A room 1605 Patentee before: Zhang Guihua |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040616 Termination date: 20120319 |